Both Semaglutide and Mounjaro represent groundbreaking approaches to addressing glucose control, and increasingly, obesity. It is a dual agonist that targets several chemicals involved in blood sugar control: the incretin hormone and GIP. It, often viewed as a brand name for Semaglutide, acts sim